PANTHEoN
Phase 1 Withdrawn
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Withdrawn
Neoadjuvant Therapy in Biliary Adenocarcinoma
Phase 1 Withdrawn
Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
Phase 1 Withdrawn
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
Phase 1 Withdrawn
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Phase 1 Withdrawn
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Phase 1 Withdrawn
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Phase 1 Withdrawn
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder
Phase 1 Withdrawn
Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma
Phase 1 Withdrawn
A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease
Phase 1 Withdrawn
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Phase 1 Withdrawn
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
Phase 1 Withdrawn
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Phase 1 Withdrawn
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1 Withdrawn
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
Phase 1 Withdrawn
Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation
Phase 1 Withdrawn
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
Phase 1 Withdrawn
WAR
Phase 1 Withdrawn
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Phase 1 Withdrawn
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Phase 1 Withdrawn
Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Withdrawn
ORCA
Phase 1 Withdrawn